PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50123F61002Bio-amt-2303: GLP natural history studies in — Texas Biomedical Research Institute

Texas Biomedical Research Institute holds $7.0M across 9 federal awards, concentrated at Department of Health and Human Services (HHS). Recompete timing centers on the Dec 31, 2028 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Texas Biomedical Research Institute

Recipient

Dec 31, 2028

PoP end

$147.3M

Obligated

541714

NAICS

AN13

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Texas Biomedical Research Institute — $90

Contract facts

Federal

Contract number75A50123F61002

Also listed as75A50122D00020-75A50123F61002

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

IncumbentTexas Biomedical Research Institute

UEIJ4EYPCJDQ1H6

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN13

Parent IDIQ / IDV75A50122D00020

Place of performanceSAN ANTONIO, TX

Related solicitationRTOR BIO-AMT-2303

PoP end (current)Dec 31, 2028

Obligated$147.3M

BIO-AMT-2303: GLP NATURAL HISTORY STUDIES IN NHP MODELS OF FILOVIRUS INFECTION is a federal award for Barda - Aspr / Daappo / Barda Dcma held by Texas Biomedical Research Institute. Estimated value $147.3M ($147.3M obligated). Current period of performance ends Dec 31, 2028. Place of performance: SAN ANTONIO, TX. Related solicitation RTOR BIO-AMT-2303.

BIO-AMT-2303: GLP NATURAL HISTORY STUDIES IN NHP MODELS OF FILOVIRUS INFECTION

Recompete timing

Public

● Expiring in 864 days

Current PoP ends Dec 31, 2028 (864 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Jul 1, 2027.

Incumbent footprint

Public record

Texas Biomedical Research Institute — $7.0M obligated across 9 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$7.0M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50123F61002?

75A50123F61002 (Bio-amt-2303: GLP natural history studies in) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $147.3M, currently held by Texas Biomedical Research Institute. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50123F61002?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50123F61002 to Texas Biomedical Research Institute.

Who is the incumbent on 75A50123F61002?

Texas Biomedical Research Institute is the incumbent with $7.0M across 9 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2028.

When does Texas Biomedical Research Institute’s 75A50123F61002 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 31, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action Jul 21, 2026